• Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • Press Releases
  • For Patients
    • Study Opportunities for Patients and Caregivers
    • Sign Up to Participate
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
  • Videos
    • Meet The Patients
    • You Ask, We Answer
    • Get To Know
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Rare Patient Voice

Helping Patients with Rare Diseases Voice Their Opinions

  • Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • Press Releases
  • For Patients
    • Study Opportunities for Patients and Caregivers
    • Sign Up to Participate
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
  • Videos
    • Meet The Patients
    • You Ask, We Answer
    • Get To Know
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Helping Patients and Caregivers Voice Their Opinions

TV ADVERTISING: Should TV Ads Reveal Drug Prices?

June 1, 2019 Wes Michael

Hi this is Wes again from the studios of Rare Patient Voice. I want to bring to your attention some information I read in a recent March issue of MM&M magazine. The heading says J & J will post drug list price in DTC TV ad.

Amid pressure from law makers, Johnson & Johnson said it would post the list price of one its treatments, the blood thinner Xarelto in a DTC television ad. The spot, said to run before the end of March, would include Xarelto’s list price of $450 to $540 per month along sign typical out-of-pocket costs at the end of the spot. It will also include the URL of a website where viewers can enter their insurance information to get specific costs.

J&J would be the first pharma company to put a treatment’s list price directly in a TV ad. In January, Eli Lilly began directing viewers to a website or phone number that had full pricing information, including the list price and typical costs for different insurance plans in ads for diabetes drug Trulicity.

Lilly’s approach follows proposals from drug industry trade group PhRMA which contends that putting only a list price in an ad would confuse consumers.

So interesting I really would like to hear what your thoughts are on that. What are the positives? What are the negatives? Let’s start a conversation. Should it be mandatory, or just voluntary? Will this keep healthcare costs under control? For anyone who has tried to obtain costs for procedures from hospitals, having public pricing published – real prices, not list prices – is a breath of fresh air. But there are a lot of issues with this and I’d like to hear what people think. I have to say, in general I am in favor of transparency. We had post our pricing on our website. But might this scare people off due to prices, when they might be covered or qualify for an assistance program? I don’t know. Post what your thoughts are! I’d be happy to see them. Let’s see what everybody thinks. Thanks.

Filed Under: You Ask We Answer Tagged With: DRUG ADVERTISING

More You Ask, We Answer Videos

Share This Video

Latest Blog Posts

  • Rare Patient Voice Expands to Europe
  • Thanks to We’re Not Drunk, We Have MS, our Terrific MS Partner
  • Thanks to WhatNext, Our Terrific Cancer Patient Partner
  • The North Wind and the Sun
  • Should companies do marketing to their market research panels?

Check Out Our YouTube Channel!

https://youtu.be/kPihaNOjekw
HTML tutorial

Read Our Newsletter

Read our Newsletter
What’s New at Rare Patient Voice?

Recent Patient

“I’ve had excellent interactions with the staff. The surveys are usually somewhat fun and feel like you’re actually helping someone or developing something new. They’ve always followed through on payment and I appreciate all the opportunities.”

Rare Patient Voice

711 Hampton Lane
Towson, Maryland 21286
ContactUs@RarePatientVoice.com
(410) 218-0527

For Patients

  • Learn about us
  • Vision, Mission and Core Values
  • Sign up to participate
  • Find us in the community
  • Read our blog for patients
  • Privacy Policy

For Related Groups

  • Are you an advocacy group for a rare disease?
  • Are you a researcher?
  • Read our blog for businesses

        
   

Rare Patient Voice, LLC, Market Research, Towson, MD
©2020. Rare Patient Voice. All Rights
Reserved. Privacy Policy. Disclaimers. Sitemap

©2021 . All Rights Reserved.

Copyright © 2021 · Genesis Framework · WordPress · Log in

Search Our Website